Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12083188 Engineered DNA binding proteins

Patent 12083188 was granted and assigned to Encoded Therapeutics, Inc. on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc.
0
Date Filed
May 28, 2020
0
Date of Patent
September 10, 2024
0
Patent Applicant
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc.
0
Patent Application Number
16886129
0
Patent Citations
‌
US Patent 7030215 Position dependent recognition of GNN nucleotide triplets by zinc fingers
0
‌
US Patent 6903185 Poly zinc finger proteins with improved linkers
0
‌
US Patent 6933113 Modulation of endogenous gene expression in cells
0
‌
US Patent 6989264 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
0
‌
US Patent 6994993 Human voltage gated sodium channel β1A subunit and methods of use
0
‌
US Patent 6998118 Targeted retrograde gene delivery for neuronal protection
0
‌
US Patent 9267151 STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness
0
‌
US Patent 9315825 Pharmacologically induced transgene ablation system
0
‌
US Patent 9624498 Methods and compositions for regulation of zinc finger protein expression
0
‌
US Patent 9845481 Synthetic regulation of gene expression
0
•••
Patent Inventor Names
Anne Tanenhaus
0
Stephanie Tagliatela
0
David Oberkofler
0
Kartik Ramamoorthi
0
Andrew Young
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12083188
0
Patent Primary Examiner
‌
Allison M Fox
0

Find more entities like US Patent 12083188 Engineered DNA binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo